Clinical trials
Active, not recruiting Sarcoma trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 5 |
| Cellectar Biosciences, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Hoffmann-La Roche | 1 |
| McMaster University | 1 |
| OncoC4, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 10 |
| Rhabdoid Tumor | 6 |
| Ependymoma | 5 |
| Glioma | 5 |
| Lymphoma, Non-Hodgkin | 5 |
| Medulloblastoma | 5 |
| Neuroblastoma | 5 |
| Osteosarcoma | 5 |
| Rhabdomyosarcoma | 5 |
| Wilms Tumor | 5 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.